1998
DOI: 10.1002/(sici)1098-1128(199801)18:1<21::aid-med2>3.0.co;2-u
|View full text |Cite
|
Sign up to set email alerts
|

Thymidylate synthase inhibition: A structure-based rationale for drug design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

1998
1998
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(17 citation statements)
references
References 94 publications
0
17
0
Order By: Relevance
“…Agents such as fluorouracil, and the newer antifolate drug Tomudex, have proved to be effective inhibitors of thymidylate synthase and are clinically established drugs in the treatment of cancer. Drugs targeting these enzymes have also been used as antibacterial and antiprotozoal agents by exploiting the differences between the catalytic sites of isoenzymes from the host and target organism [15][16][17]. With such considerable effort put into designing drugs against these enzymes, it is surprising that so little attention has been paid to the inhibition of SHMT.…”
Section: Introductionmentioning
confidence: 99%
“…Agents such as fluorouracil, and the newer antifolate drug Tomudex, have proved to be effective inhibitors of thymidylate synthase and are clinically established drugs in the treatment of cancer. Drugs targeting these enzymes have also been used as antibacterial and antiprotozoal agents by exploiting the differences between the catalytic sites of isoenzymes from the host and target organism [15][16][17]. With such considerable effort put into designing drugs against these enzymes, it is surprising that so little attention has been paid to the inhibition of SHMT.…”
Section: Introductionmentioning
confidence: 99%
“…The bio‐profiling studies suggested that the halogen‐substituted phthaleins exhibit potential as cancer chemotherapeutics. Phenolphthalein 1 , tetrabromophenolphthalein 6 , tetrachlorophenolphthalein 7 and tetraiodophenolphthalein 8 have been reported as TS inhibitors .…”
Section: Biological Applications Of Phthalein Dyesmentioning
confidence: 99%
“…The methylene group and the hydride are transferred from different sites of the folate to the substrate 2’-deoxyuridine-5’-monophosphate (dUMP), thus forming dTMP (Scheme 2). TSase is overexpressed in cancerous cells to facilitate faster cell growth, [59] which makes TSase a target for chemotherapeutic drugs, but common drugs such as antifolates and 5-fluorouracil often interfere with the metabolic processes of healthy cells, resulting in toxicity [60]. Careful investigation of the TSase mechanism may lead to the discovery of drugs that selectively target malignant tumor cells.…”
Section: Folate In Thymidylate Synthasementioning
confidence: 99%